Actuate Therapeutics, Inc. (ACTU) Income Statement
6 Followers
Actuate Therapeutics, Inc. Income Statement
Last quarter (Q ), Actuate Therapeutics, Inc.'s total revenue was $―, a decrease of ― from previous quarter. In Q, Actuate Therapeutics, Inc.'s net income was $-8.30M. See Actuate Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23
Total Revenue
-
Cost of Revenue
-
Gross Profit
-
Operating Expense
$ 24.97M
Operating Income
$ -24.97M
Net Non Operating Interest Income Expense
$ 309.03K
Other Income Expense
$ 79.82K
Pretax Income
$ -24.74M
Tax Provision
-
Earnings From Equity Interest Net Of Tax
-
Net Income Common Stockholders
$ -24.74M
Basic EPS
$ -17.24
Diluted EPS
$ -17.24
Basic Average Shares
$ 1.43M
Diluted Average Shares
$ 1.43M
Dividend Per Share
-
Total Operating Income As Reported
-
Reported Normalized Basic E P S
-
Reported Normalized Diluted E P S
-
Rent Expense Supplemental
-
Total Expenses
$ 24.97M
Net Income From Continuing And Discontinued Operation
$ -24.74M
Normalized Income
$ -18.19M
Interest Expense
-
EBIT
$ -24.70M
EBITDA
$ -24.70M
Currency in USD
Actuate Therapeutics, Inc. Earnings and Revenue History